CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- PositionCurrent ratio is 53.2×, higher than 95% of its Medical Devices peers (median 3.83×)
- FinancialsAltman Z-Score 12.19: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.20%
Annual Rate
CNY 0.03Paid unknown
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
Aug 6, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.12BCNY314.79M · vs all stocks (USD)
Trailing P/E
157.90xvs Medical Devices peers
Revenue (TTM)
229.96MCNY34.20M · vs all stocks (USD)
Profit Margin
6.18%vs Medical Devices peers
Beta
0.5780xvs all stocks
52-Week Change
-26.15%vs all stocks
Forward Annual Dividend Yield
0.20%vs all stocks
Market Capitalization
2.12BCNY314.79M · vs all stocks (USD)
Enterprise Value
1.06BCNY157.13M · vs all stocks (USD)
Trailing P/E
157.90xvs Medical Devices peers
Price to Sales (TTM)
9.41xvs Medical Devices peers
Price to Book (MRQ)
1.51xvs Medical Devices peers
Enterprise to Revenue
4.59xvs Medical Devices peers
Enterprise to EBITDA
47.60xvs Medical Devices peers
Gross Margin
60.94%vs Medical Devices peers
Profit Margin
6.18%vs Medical Devices peers
Operating Margin
-3.45%vs Medical Devices peers
Return on Assets (TTM)
0.05%vs Medical Devices peers
Return on Equity (TTM)
0.71%vs Medical Devices peers
Revenue (TTM)
229.96MCNY34.20M · vs all stocks (USD)
Revenue per Share (TTM)
1.56CNYUpdated Aug 21, 2026Quarterly Revenue Growth
14.70%vs Medical Devices peers
Gross Profit (TTM)
157.34MCNY23.40M · vs all stocks (USD)
EBITDA (TTM)
18.72MCNY2.78M · vs all stocks (USD)
Net Income (TTM)
14.21MCNY2.11M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
35.50%vs Medical Devices peers
Operating Cash Flow (TTM)
23.65MCNY3.52M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-4.30MCNY-639.19K · vs all stocks (USD)
Forward Annual Dividend Rate
0.0300CNYUpdated Aug 21, 2026Forward Annual Dividend Yield
0.20%vs all stocks
Trailing Annual Dividend Rate
0.0300CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.20%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
12.75MCNYFY2025 · Dec 31, 2025Revenue
223.74MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
70.12MCNYFY2025 · Dec 31, 2025Gross Profit
153.62MCNYFY2025 · Dec 31, 2025Operating Income
-3.79MCNY-563.96K · vs all stocks (USD)
Pre-tax Income
12.29MCNYFY2025 · Dec 31, 2025Income Tax Expense
2.79MCNYFY2025 · Dec 31, 2025Net Income
9.50MCNYFY2025 · Dec 31, 2025EBIT
14.66MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
18.72MCNYFY2025 · Dec 31, 2025Research & Development
39.25MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
42.21MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.30MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
356.50KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
2.38MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1000CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
138.39MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
138.39MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
9.50MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
4.34MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
32.75MCNYFY2025 · Dec 31, 2025Free Cash Flow
3.83MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
169.06MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
9.50MCNYFY2025 · Dec 31, 2025Other Non-cash Items
11.81MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
29.99MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-18.55MCNYFY2025 · Dec 31, 2025Capital Expenditures
-28.93MCNYFY2025 · Dec 31, 2025Purchase of Investments
-30.00MCNYFY2025 · Dec 31, 2025Sale of Investments
25.12MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-33.80MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-4.69MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-2.28MCNYFY2025 · Dec 31, 2025Other Financing Charges
13.24MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
6.26MCNYFY2025 · Dec 31, 2025Shares Outstanding
137.01MSharesUpdated Aug 21, 2026Float Shares
96.90MSharesUpdated Aug 21, 2026% Held by Insiders
30.96%vs all stocks
% Held by Institutions
3.47%vs all stocks
Total Cash (MRQ)
1.02BCNY151.69M · vs all stocks (USD)
Total Cash per Share (MRQ)
7.45CNYUpdated Aug 21, 2026Total Debt (MRQ)
15.16MCNY2.26M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0105xvs Medical Devices peers
Current Ratio (MRQ)
53.20xvs Medical Devices peers
Book Value per Share (MRQ)
10.48CNYUpdated Aug 21, 2026Total Assets
1.56BCNY232.57M · vs all stocks (USD)
Total Current Assets
1.22BCNYFY2025 · Dec 31, 2025Total Liabilities
116.52MCNYFY2025 · Dec 31, 2025Total Non-current Assets
340.35MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
34.54MCNYFY2025 · Dec 31, 2025Total Current Liabilities
81.98MCNYFY2025 · Dec 31, 2025Cash
169.07MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
169.07MCNYFY2025 · Dec 31, 2025Other Short-term Investments
913.63MCNYFY2025 · Dec 31, 2025Accounts Receivable
27.46MCNYFY2025 · Dec 31, 2025Inventory
76.94MCNYFY2025 · Dec 31, 2025Accounts Payable
12.41MCNYFY2025 · Dec 31, 2025Short-term Debt
36.90MCNYFY2025 · Dec 31, 2025Other Current Liabilities
735.06KCNYFY2025 · Dec 31, 2025Long-term Debt
11.03MCNYFY2025 · Dec 31, 2025Common Stock (Book)
137.01MCNYFY2025 · Dec 31, 2025Retained Earnings
264.10MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.45BCNY215.24M · vs all stocks (USD)
52-Week Low
12.94CNYUpdated Aug 21, 202652-Week High
29.88CNYUpdated Aug 21, 202652-Week Change
-26.15%vs all stocks
Beta
0.5780xvs all stocks
50-Day MA
14.89CNYUpdated Aug 21, 2026200-Day MA
19.63CNYUpdated Aug 21, 2026Avg 10-Day Volume
2.76MSharesUpdated Aug 21, 2026Avg 30-Day Volume
3.40MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.1000CNYUpdated Aug 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Cash Backing With OCF Coverage And Cash Near Total Debt
Cash on hand covers most or all of its total debt, and cash flow matches reported earnings.
Reads
Where is this company structurally exposed?
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 53.2×, higher than 95% of its Medical Devices peers (median 3.83×)Significant
Current ratio: 53.20Industry median: 3.83Industry P95: 12.54Peers compared: 102
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.61Profit Margin: 0.06
Financial Health
Altman Z-Score 12.19: safe zoneNotable
Altman Z-Score: 12.19
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Animalcare Group Plc
Tier 1ProductionApproval-Gated PipelineRuleFlow
Eledon Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Medy-Tox Inc.
Tier 1ProductionApproval-Gated PipelineRule
Guiyang Xintian Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Santhera Pharmaceuticals Holding AG
Tier 1ProductionApproval-Gated PipelineRuleRisk
Won Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shin Poong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Lavipharm S.A.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Solara Active Pharma Sciences Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Dishman Carbogen Amcis Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Suzhou Jinhong Shun Auto Co., Ltd.
2 interpretationsPartial Recovery After Sharp DeclineLow-Leverage Liquidity Configuration
Zilltek Technology Corp.
2 interpretationsLow-Leverage Liquidity ConfigurationCash Backing With OCF Coverage And Cash Near Total Debt
Beijing Labtech Instrument Co., Ltd.
2 interpretationsPartial Recovery After Sharp DeclineLow-Leverage Liquidity Configuration